Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Updates for media on the latest products, offerings and developments across our business.
Jun 3, 2020
91Ï㽶ÊÓƵ will continue to put our hearts into making our communities better through our programs promoting diversity & inclusion and corporate responsibility.
Jun 2, 2020
91Ï㽶ÊÓƵ today announced the appointment of Charles Lickfold as Senior Vice President, Chief Information Officer. Mr. Lickfold succeeds John McGill, who plans to retire in September 2020.
May 21, 2020
91Ï㽶ÊÓƵ announced a deal to acquire a clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan, from Teva-Takeda Pharmaceuticals, Nagoya Aichi, Japan.
May 20, 2020
91Ï㽶ÊÓƵ today announced that Jean-François Chaubard, Senior Director, Open Innovation at 91Ï㽶ÊÓƵ Cell & Gene Therapy, will be presenting at the ISCT 2020 Paris Virtual conference.
May 18, 2020
Triphase Accelerator and 91Ï㽶ÊÓƵ today announced interim results for Triphase Accelerator’s multi-center, open-label, monotherapy study of TRPH-222 in heavily pre-treated patients with relapsed and/or refractory B-cell lymphoma.
May 14, 2020
91Ï㽶ÊÓƵ today announced that it will present at the upcoming conference, ‘Outsourcing in Clinical Trials 2020 – A Virtual Experience’.
May 13, 2020
91Ï㽶ÊÓƵ today announced a collaboration with Ennaid Therapeutics to develop an oral, antiviral treatment targeted at COVID-19.
May 7, 2020
91Ï㽶ÊÓƵ today welcomed the news by Humanigen, Inc., that it has dosed the first COVID-19 patient in its previously announced Phase 3 study for lenzilumab.
May 4, 2020
Arcturus and 91Ï㽶ÊÓƵ today announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate, intended to protect against the SARS-CoV-2 coronavirus.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
